Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery

Phase 1

Active, not recruiting

Conditions: Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer

Interventions: Other: laboratory biomarker analysis
Drug: lyophilized black raspberry confection
Procedure: quality-of-life assessment
Dietary Supplement: dietary intervention
Other: questionnaire administration

First Posted Date: 2013-04-04

Last Posted Date: 2024-02-06

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 56

Registration Number: NCT01823562

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Stage IV A Bladder Cancer
Stage IV B Colon Cancer
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV A Rectal Cancer
Stage IV B Rectal Cancer

Interventions: Procedure: PET Scan
Procedure: CT Scan
Radiation: fludeoxyglucose F 18
Procedure: computer-aided detection/diagnosis

First Posted Date: 2013-03-29

Last Posted Date: 2016-03-02

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 21

Registration Number: NCT01821105

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States

Lymph Node Mapping in Patients With Endometrial Cancer

Not Applicable

Completed

Conditions: Endometrial Cancer

Interventions: Procedure: sentinel lymph node detection
Drug: indocyanine green solution
Drug: isosulfan blue
Procedure: sentinel lymph node biopsy

First Posted Date: 2013-03-26

Last Posted Date: 2023-03-22

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 204

Registration Number: NCT01818739

Locations: 🇺🇸
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Not Applicable

Completed

Conditions: Tongue Cancer
Oral Cavity Verrucous Carcinoma
Stage 0 Lip and Oral Cavity Cancer
Lip and Oral Cavity Squamous Cell Carcinoma

Interventions: Procedure: fluorescence imaging
Procedure: biopsy
Procedure: examination
Procedure: Comparison of surgical margins by COE vs. DVFE

First Posted Date: 2013-03-22

Last Posted Date: 2020-01-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 68

Registration Number: NCT01816841

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 2

Terminated

Conditions: Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
Nodal Marginal Zone B-cell Lymphoma
Recurrent Adult Burkitt Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Marginal Zone Lymphoma
Splenic Marginal Zone Lymphoma
Waldenström Macroglobulinemia
Recurrent Grade 3 Follicular Lymphoma

Interventions: Drug: alisertib
Biological: rituximab
Other: laboratory biomarker analysis

First Posted Date: 2013-03-15

Last Posted Date: 2018-06-06

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 14

Registration Number: NCT01812005

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer

Not Applicable

Completed

Conditions: Rectal Cancer
Colon Cancer

Interventions: Other: educational intervention
Other: questionnaire administration

First Posted Date: 2013-02-28

Last Posted Date: 2014-10-16

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 284

Registration Number: NCT01801059

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer

Not Applicable

Withdrawn

Conditions: Lung Cancer

Interventions: Drug: methylprednisolone
Radiation: fludeoxyglucose F 18
Procedure: positron emission tomography
Procedure: computed tomography

First Posted Date: 2013-02-12

Last Posted Date: 2018-06-28

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Registration Number: NCT01789892

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Phase 2

Completed

Conditions: Ovarian Sarcoma
Stage I Uterine Sarcoma
Stage I Vulvar Cancer
Stage IA Ovarian Epithelial Cancer
Stage IC Fallopian Tube Cancer
Stage IIA Fallopian Tube Cancer
Stage IIA Ovarian Germ Cell Tumor
Stage IIIA Ovarian Germ Cell Tumor
Stage IIIB Endometrial Carcinoma
Stage IIIB Fallopian Tube Cancer

Interventions: Other: behavioral, psychological or informational intervention

First Posted Date: 2013-01-10

Last Posted Date: 2018-05-30

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT01764802

Locations: 🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Not Applicable

Completed

Conditions: Recurrent Endometrial Carcinoma
Recurrent Ovarian Epithelial Cancer
Recurrent Vulvar Cancer
Fatigue
Leydig Cell Tumor
Recurrent Primary Peritoneal Cavity Cancer
Pain
Anxiety Disorder
Depression
Peritoneal Carcinomatosis

Interventions: Other: questionnaire administration
Procedure: quality-of-life assessment
Procedure: psychosocial assessment and care
Behavioral: behavioral intervention
Other: cognitive intervention
Other: educational intervention

First Posted Date: 2013-01-10

Last Posted Date: 2015-10-09

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 39

Registration Number: NCT01764789

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States

Cognitive Therapy in Reducing Depression in Patients With Cancer

Phase 2

Completed

Conditions: Depression

Interventions: Procedure: quality-of-life assessment
Other: questionnaire administration
Other: counseling intervention
Behavioral: behavioral intervention

First Posted Date: 2012-12-12

Last Posted Date: 2015-06-04

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 25

Registration Number: NCT01748734

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy